World Kidney Day provided an opportunity to reflect on the success of kidney transplantation as a therapy for end stage renal disease. The global burden of chronic kidney disease is increasing and is projected to become the fifth most common cause of years of lives lost globally by 2040.
The Mediclinic City Hospital’s transplant programme offers patients suffering from end stage renal disease an alternative to dialysis. The transplant team provides comprehensive, multidisciplinary care for potential transplant recipients and donors, from initial consultation through to the procedure of donation or transplant, and ongoing treatment.
The programme enjoys a strong and supportive partnership with Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in propelling transplant to the forefront of healthcare, in the process helping to transform the nation's laws on organ donation and transplant and making the service available to the UAE's citizens and residents.
This year Mediclinic City Hospital also signed a three-party agreement with Al Jalila Children’s Specially Hospital and MBRU to collaborate on activities related to organ transplant services. The collaboration will ensure that the three entities work closely with the National Transplant Program led by MOHAP as well as other health authorities, government and non-government entities to support transplant efforts in the UAE and the region. . This form of collaboration has been highlighted by H.E. Dr. Amin Hussain Al Amiri, Assistant Undersecretary of the Minister of Health and Prevention, as a sought after and valued asset in the present and future healthcare in the UAE.
In June 2016 Mediclinic City Hospital was the first hospital in Dubai to perform a deceased donor kidney transplant. The programme covers all residents of the UAE, citizens and expatriates alike, and is considered the best option for residents of the Northern Emirates considering a transplant. The programme has been accredited by the Saudi Center for Organ Transplantation (SCOT), the reference centre for organ donation and transplant for the GCC; Dubai Healthcare City Authority (DHCA) and the Ministry of Health and Prevention (MOHAP). Furthermore, the programme has been assessed against the Joint Commission International standards and is fully accredited.
Dr. Ramzi Ayache, Consultant Nephrologist at Mediclinic City Hospital, says, “We offer both living-related and deceased donor transplant options to patients suffering from end stage renal disease. Our ethos is to provide the transplant option to any patient who chooses to explore transplant in an equitable, transparent and just manner. All our post renal transplant patients are alive and healthy maintaining an excellent renal function and a graft survival of 100%. None of the patients have required dialysis post-surgery as they had an immediate graft function.”
The transplant committee at Mediclinic City Hospital provides clinical oversight by assessing the suitability of every patient and formally agrees on the most appropriate treatment plan for all cases before proceeding to donation or placing a patients on a wait list with the National Transplant Committee.
Mr. Vinay B. Pokale, a recent renal transplant patient at Mediclinic City Hospital, said “Each passing week after my surgery, I have seen improvement and with each improvement I feel hopeful. I don’t know who my donor was, but because of the selfless actions done by the family members of the deceased to make a donation like this, I have been blessed with a second chance in life. I will be forever grateful.”
Dr. Farhad Janahi, Assistant Professor of Surgery, MBRU, Consultant Urologist and part of the Mediclinic City Hospital Transplant Team, summed up the efforts that go into this program, “Our entire community has embraced this endeavor. We are extremely grateful to all who made this possible especially the UAE government, SCOT, MOHAP, Dubai Airports, General Directorate of Residency and Foreigner Affairs, Dubai Customs, Dubai Police, Dubai Ambulance and all our hospital staff for their tireless work. Last but not the least, our donor families, who in their time of grief thought of giving life to another human. They not only brought joy to our recipients but their entire families.”
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
